Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characteristics of Lyme Arthritis (ArthLyme)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03510507
Recruitment Status : Unknown
Verified January 2018 by University Hospital, Strasbourg, France.
Recruitment status was:  Recruiting
First Posted : April 27, 2018
Last Update Posted : April 27, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Lyme disease is due to Borrelia burgdorferi sensu lato and is transmitted by a tick vector of the genus Ixodes. One of the clinical forms of this disease in the disseminated phase is the appearance of arthritis, classically mono or oligo-arthritis in the large joints.

Condition or disease
Lyme Arthritis

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 38 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Characteristics of Positive Lyme PCR Arthritis, Data From CNR Borrelia 2011-2016
Actual Study Start Date : January 20, 2018
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : January 2019

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Retrospective study of clinical and biological data of French patients with Lyme arthritis between 2011 and 2016 [ Time Frame: The period from 2011 to 2016 will be examined ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient diagnosed with Lyme arthritis and confirmed by PCR of joint fluid at CNR Borrelia between 2011 and 2016
Criteria

Inclusion Criteria:

  • Age >18 years
  • Diagnosis of Lyme arthritis confirmed by PCR of joint fluid at CNR Borrelia between 2011 and 2016
  • Patient who has agreed to use his medical data for research purposes

Exclusion Criteria:

- Refusal to participate in the study

Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03510507


Contacts
Layout table for location contacts
Contact: Benoit JAULHAC, MD, PhD 33 3 69 55 14 52 benoit.jaulhac@chru-strasbourg.fr
Contact: Antoine GRILLON, MD 33 3 69 55 15 82 antoine.grillon@chru-strasbourg.fr

Locations
Layout table for location information
France
Laboratoire de Bacteriologie - Ptm Recruiting
Strasbourg, France, 67091
Contact: Benoit JAULHAC, MD, PhD    33 3 69 55 14 52    benoit.jaulhac@chru-strasbourg.fr   
Contact: Antoine GRILLON, MD    33 3 69 55 15 82    antoine.grillon@chru-strasbourg.fr   
Principal Investigator: Benoit JAULHAC, MD, PhD         
Sub-Investigator: Antoine GRILLON, MD         
Sub-Investigator: Jean SIBILIA, MD, PhD         
Sub-Investigator: Laurent ARNAUD, MD, PhD         
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Layout table for investigator information
Study Director: Benoit JAULHAC, MD, PhD University Hospital, Strasbourg, France
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT03510507    
Other Study ID Numbers: 6971
First Posted: April 27, 2018    Key Record Dates
Last Update Posted: April 27, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Strasbourg, France:
Lyme arthritis
Borrelia burgdorferi
vector tick
Arthritis
joints
Additional relevant MeSH terms:
Layout table for MeSH terms
Lyme Disease
Arthritis
Joint Diseases
Musculoskeletal Diseases
Gram-Negative Bacterial Infections
Bacterial Infections
 Bacterial Infections and Mycoses
Infections
Borrelia Infections
Spirochaetales Infections
Tick-Borne Diseases
Vector Borne Diseases